BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37968017)

  • 1. Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension.
    Lowery MM; Hill NS; Wang L; Rosenzweig EB; Bhat A; Erzurum S; Finet JE; Jellis CL; Kaur S; Kwon DH; Nawabit R; Radeva M; Beck GJ; Frantz RP; Hassoun PM; Hemnes AR; Horn EM; Leopold JA; Rischard FP; Mehra R;
    J Am Coll Cardiol; 2023 Nov; 82(21):1989-2005. PubMed ID: 37968017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure Overload.
    van Wezenbeek J; Kianzad A; van de Bovenkamp A; Wessels J; Mouratoglou SA; Braams NJ; Jansen SMA; Meulblok E; Meijboom LJ; Marcus JT; Vonk Noordegraaf A; José Goumans M; Jan Bogaard H; Handoko ML; de Man FS
    Circ Heart Fail; 2022 Feb; 15(2):e008726. PubMed ID: 34937392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise cardiac MRI unmasks right ventricular dysfunction in acute hypoxia and chronic pulmonary arterial hypertension.
    Jaijee S; Quinlan M; Tokarczuk P; Clemence M; Howard LSGE; Gibbs JSR; O'Regan DP
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H950-H957. PubMed ID: 29775415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients.
    Lan WF; Deng Y; Dai P; Wu DD; Hu J; Liao J; Meng H
    Lupus; 2024 Feb; 33(2):155-165. PubMed ID: 38182135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
    Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
    ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
    Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.
    Liu A; Schreier D; Tian L; Eickhoff JC; Wang Z; Hacker TA; Chesler NC
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H273-83. PubMed ID: 24906919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic value of right ventricular strain in patients with pulmonary arterial hypertension and relatively preserved functional capacity studied with echocardiography and magnetic resonance.
    da Costa Junior AA; Ota-Arakaki JS; Ramos RP; Uellendahl M; Mancuso FJ; Gil MA; Fischer CH; Moises VA; de Camargo Carvalho AC; Campos O
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):39-46. PubMed ID: 27566191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right Heart End-Systolic Remodeling Index Strongly Predicts Outcomes in Pulmonary Arterial Hypertension: Comparison With Validated Models.
    Amsallem M; Sweatt AJ; Aymami MC; Kuznetsova T; Selej M; Lu H; Mercier O; Fadel E; Schnittger I; McConnell MV; Rabinovitch M; Zamanian RT; Haddad F
    Circ Cardiovasc Imaging; 2017 Jun; 10(6):. PubMed ID: 28592589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular myocardial deoxygenation in patients with pulmonary artery hypertension.
    Sree Raman K; Shah R; Stokes M; Walls A; Woodman RJ; Perry R; Walker JG; Proudman S; De Pasquale CG; Celermajer DS; Selvanayagam JB
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):22. PubMed ID: 33678188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
    J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
    Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Oxygen Starvation in Right Ventricular Decompensation and Failure in Pulmonary Arterial Hypertension.
    Oknińska M; Zajda K; Zambrowska Z; Grzanka M; Paterek A; Mackiewicz U; Szczylik C; Kurzyna M; Piekiełko-Witkowska A; Torbicki A; Kieda C; Mączewski M
    JACC Heart Fail; 2024 Feb; 12(2):235-247. PubMed ID: 37140511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
    Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
    Park JF; Clark VR; Banerjee S; Hong J; Razee A; Williams T; Fishbein G; Saddic L; Umar S
    Circ Heart Fail; 2021 Feb; 14(2):e007058. PubMed ID: 33541093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung Disease.
    Prins KW; Rose L; Archer SL; Pritzker M; Weir EK; Olson MD; Thenappan T
    J Am Heart Assoc; 2019 Jan; 8(2):e011464. PubMed ID: 30646788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Beat Right Ventricular-Arterial Coupling Predicts Clinical Worsening in Pulmonary Arterial Hypertension.
    Hsu S; Simpson CE; Houston BA; Wand A; Sato T; Kolb TM; Mathai SC; Kass DA; Hassoun PM; Damico RL; Tedford RJ
    J Am Heart Assoc; 2020 May; 9(10):e016031. PubMed ID: 32384024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic Differences in Connective Tissue Disease-Associated Versus Idiopathic Pulmonary Arterial Hypertension in the PVDOMICS Cohort.
    Simpson CE; Hemnes AR; Griffiths M; Grunig G; Tang WHW; Garcia JGN; Barnard J; Comhair SA; Damico RL; Mathai SC; Hassoun PM;
    Arthritis Rheumatol; 2023 Dec; 75(12):2240-2251. PubMed ID: 37335853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric evaluation of right ventricular function in pulmonary arterial hypertension associated with congenital heart disease.
    Fournier E; Selegny M; Amsallem M; Haddad F; Cohen S; Valdeolmillos E; Le Pavec J; Humbert M; Isorni MA; Azarine A; Sitbon O; Jais X; Savale L; Montani D; Fadel E; Zoghbi J; Belli E; Hascoët S
    Rev Esp Cardiol (Engl Ed); 2023 May; 76(5):333-343. PubMed ID: 35940550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ-level right ventricular dysfunction with preserved Frank-Starling mechanism in a mouse model of pulmonary arterial hypertension.
    Wang Z; Patel JR; Schreier DA; Hacker TA; Moss RL; Chesler NC
    J Appl Physiol (1985); 2018 May; 124(5):1244-1253. PubMed ID: 29369739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.